Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Sina Schwarzkopf"'
Autor:
Sina Schwarzkopf, Adalbert Krawczyk, Dietmar Knop, Hannes Klump, Andreas Heinold, Falko M. Heinemann, Laura Thümmler, Christian Temme, Marianne Breyer, Oliver Witzke, Ulf Dittmer, Veronika Lenz, Peter A. Horn, Monika Lindemann
Publikováno v:
Emerging Infectious Diseases, Vol 27, Iss 1, Pp 122-129 (2021)
We investigated immune responses against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among a group of convalescent, potential blood donors in Germany who had PCR-confirmed SARS-CoV-2 infection. Sixty days after onset of symptoms, 13/
Externí odkaz:
https://doaj.org/article/2c9c32d7cac243e7b5a17ab7e449c7a2
Autor:
Monika Lindemann, Vesna Klisanin, Laura Thümmler, Neslinur Fisenkci, Nikolaos Tsachakis-Mück, Markus Ditschkowski, Sina Schwarzkopf, Hannes Klump, Hans Christian Reinhardt, Peter A. Horn, Michael Koldehoff
Publikováno v:
Vaccines, Vol 9, Iss 10, p 1075 (2021)
The cellular response to SARS-CoV-2 vaccination and infection in allogeneic hematopoietic stem cell transplant (HSCT) recipients is not yet clear. In the current study, HSCT recipients prior to and post vaccination were tested for SARS-CoV-2-specific
Externí odkaz:
https://doaj.org/article/172dde52a461444c83e6e9f9983f2a5d
Autor:
Laura Thümmler, Sina Schwarzkopf, Dietmar Knop, J. Alexander Ross, Victoria Berg, Peter A. Horn, Monika Lindemann
Publikováno v:
Diagnostics, Vol 11, Iss 8, p 1439 (2021)
Herd immunity is essential to control severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2), especially in immunocompromised patients. Convalescent individuals should be vaccinated later due to vaccine shortage, as studies show that neutr
Externí odkaz:
https://doaj.org/article/c7d6bda8e9794da9b914863dac3979e7
Autor:
Cornelius Knabbe, Hannes Klump, Michael Koldehoff, Frank Herbstreit, Adalbert Krawczyk, Ulf Dittmer, Peter A. Horn, Dietmar Knop, Andreas Heinold, Veronika Lenz, Sebastian Dolff, Mira Alt, Oliver Witzke, Nina K. Steckel, Leonie Schipper, Thorsten Brenner, Gabriele Hutschenreuter, Ulrich Wilhelm Aufderhorst, Monika Lindemann, Johannes C. Fischer, Falko M. Heinemann, Lara Meller, Sina Schwarzkopf
Publikováno v:
Transfusion
Background Infection with severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) may be life‐threatening, and specific antiviral drugs are currently not available. However, first studies indicated that convalescent plasma treatment might
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96659602f6a2f0d4334dcd5c50826923
http://europepmc.org/articles/PMC8251157
http://europepmc.org/articles/PMC8251157
Autor:
Andreas Heinold, Laura Thümmler, Oliver Witzke, Ulf Dittmer, Peter A. Horn, Monika Lindemann, Adalbert Krawczyk, Dietmar Knop, Hannes Klump, Falko M. Heinemann, Sina Schwarzkopf, Marianne Breyer, Christian Temme, Veronika Lenz
Publikováno v:
Emerging Infectious Diseases, Vol 27, Iss 1, Pp 122-129 (2021)
Emerging Infectious Diseases
Emerging Infectious Diseases
We investigated immune responses against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among a group of convalescent, potential blood donors in Germany who had PCR-confirmed SARS-CoV-2 infection. Sixty days after onset of symptoms, 13/
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::94d2c09096cc1e11cb8c23436b9a48aa
https://doi.org/10.3201/eid2701.203772
https://doi.org/10.3201/eid2701.203772
Autor:
Adalbert Krawczyk, Laura Thümmler, Eva-Maria Skoda, Anja Gäckler, Margarethe Konik, Ulf Dittmer, Olympia E. Anastasiou, Oliver Witzke, Benjamin Wilde, Markus Zettler, Vera Rebmann, Christian Taube, Christoph Schöbel, Sina Schwarzkopf, Peter A. Horn, Monika Lindemann, Lara Meller, Hana Rohn, Thorsten Brenner, Mirko Trilling, Sebastian Dolff, Leonie Schipper
Publikováno v:
Journal of Clinical Medicine, Vol 10, Iss 4606, p 4606 (2021)
Journal of Clinical Medicine
Volume 10
Issue 19
Journal of Clinical Medicine
Volume 10
Issue 19
The coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is currently the greatest medical challenge. Although crucial to the future management of the pandemic, the factors affecting the persi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e43f0cb466ace5c3c6b7f68ee517e4fb
https://www.mdpi.com/2077-0383/10/19/4606
https://www.mdpi.com/2077-0383/10/19/4606
Autor:
Nikolaos Tsachakis-Mück, Sina Schwarzkopf, Laura Thümmler, Neslinur Fisenkci, Monika Lindemann, Peter A. Horn, Hannes Klump, Markus Ditschkowski, Hans Christian Reinhardt, Michael Koldehoff, Vesna Klisanin
Publikováno v:
Vaccines, Vol 9, Iss 1075, p 1075 (2021)
Vaccines
Volume 9
Issue 10
Vaccines
Volume 9
Issue 10
The cellular response to SARS-CoV-2 vaccination and infection in allogeneic hematopoietic stem cell transplant (HSCT) recipients is not yet clear. In the current study, HSCT recipients prior to and post vaccination were tested for SARS-CoV-2-specific
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::705a3b2519e24ba1e5e7b38fce7f6de7
https://www.mdpi.com/2076-393X/9/10/1075
https://www.mdpi.com/2076-393X/9/10/1075
Autor:
Adalbert Krawczyk, Hannes Klump, Marianne Breyer, Veronika Lenz, Laura Thümmler, Lukas van de Sand, Peter A. Horn, Sebastian Dolff, Monika Lindemann, Leonie Schipper, Oliver Witzke, Margarethe Konik, Dietmar Knop, Maximillian Platte, Hana Rohn, Christian Temme, Sina Schwarzkopf, Ulf Dittmer, Maren Bormann
Publikováno v:
Journal of Medical Virology
When patients with chronic kidney disease are infected with severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) they can face two specific problems: virus‐specific immune responses may be impaired and remdesivir, an antiviral drug desc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6b41e46a5278b210c9b50b749d1f671
https://pubmed.ncbi.nlm.nih.gov/33527424
https://pubmed.ncbi.nlm.nih.gov/33527424
Autor:
Dietmar Knop, Margarethe Konik, Lukas van de Sand, Ulf Dittmer, Hana Rohn, Christian Temme, Laura Thümmler, Marianne Breyer, Sebastian Dolff, Leonie Schipper, Peter A. Horn, Maren Bormann, Sina Schwarzkopf, Veronika Lenz, Monika Lindemann, Oliver Witzke, Maximillian Platte, Adalbert Krawczyk, Hannes Klump
BackgroundWhen patients with chronic kidney disease are infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) they can face two specific problems: Virus-specific immune responses may be impaired and remdesivir, an antiviral drug
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c5bc4cfc290364b493514ee1a91d4cae
https://doi.org/10.1101/2020.12.09.20239673
https://doi.org/10.1101/2020.12.09.20239673
